We are live on ! Find out more
NGNE icon

Neurogene
NGNE

82 hedge funds and large institutions have $249M invested in Neurogene in 2021 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 27 increasing their positions, 24 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 24

0% more funds holding

Funds holding: 82 → 82 (0)

0% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 9

0.1% less ownership

Funds ownership: 3.28% → 3.18% (-0.1%)

27% less capital invested

Capital invested by funds: $342M → $249M (-$93.1M)

64% less call options, than puts

Call options by funds: $703K | Put options by funds: $1.97M

Holders
82
Holders Change
–
Holders Change %
0%
% of All Funds
1.43%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
27
Reduced
24
Closed
9
Calls
$703K
Puts
$1.97M
Net Calls
-$1.26M
Net Calls Change
+$434K

Top Buyers

Rank Fund Capital Flow
1
CS
Candriam SCA
Luxembourg
+$5.66M
2
Morgan Stanley
Morgan Stanley
New York
+$3.16M
3
Bank of America
Bank of America
North Carolina
+$1.69M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$832K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$502K

Top Sellers

Rank Fund Capital Flow
1
EC
EcoR1 Capital
California
-$8.45M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
-$4.71M
3
State Street
State Street
Massachusetts
-$3.8M
4
RG
Redmile Group
California
-$2.19M
5
Goldman Sachs
Goldman Sachs
New York
-$1.44M
Name Holding Trade Value Shares
Change 		Change in
Stake
Swiss National Bank
26
Swiss National Bank
Switzerland
$682K +$86.3K +390 +12%
Two Sigma Advisers
27
Two Sigma Advisers
New York
$551K -$228K -1,030 -26%
Citigroup
28
Citigroup
New York
$547K -$319K -1,440 -33%
RhumbLine Advisers
29
RhumbLine Advisers
Massachusetts
$466K +$169K +763 +43%
California State Teachers Retirement System (CalSTRS)
30
California State Teachers Retirement System (CalSTRS)
California
$449K -$1.77K -8 -0.3%
HPWM
31
Highland Private Wealth Management
Washington
$434K – – –
New York State Common Retirement Fund
32
New York State Common Retirement Fund
New York
$431K -$54K -244 -9%
Los Angeles Capital Management
33
Los Angeles Capital Management
California
$428K +$210K +948 +69%
Susquehanna International Group
34
Susquehanna International Group
Pennsylvania
$388K +$261K +1,180 +128%
Two Sigma Investments
35
Two Sigma Investments
New York
$361K +$268K +1,211 +163%
SCM
36
Sio Capital Management
New York
$354K – – –
Dimensional Fund Advisors
37
Dimensional Fund Advisors
Texas
$343K +$249K +1,124 +153%
Rafferty Asset Management
38
Rafferty Asset Management
New York
$335K -$372K -1,682 -48%
T. Rowe Price Associates
39
T. Rowe Price Associates
Maryland
$328K +$54.6K +247 +16%
Cerity Partners
40
Cerity Partners
New York
$286K – – –
AllianceBernstein
41
AllianceBernstein
Tennessee
$244K +$46.5K +210 +19%
PCS
42
Personal CFO Solutions
New Jersey
$219K +$55.3K +250 +27%
CGL
43
Clarius Group LLC
Washington
$217K – – –
Deutsche Bank
44
Deutsche Bank
Germany
$208K +$664 +3 +0.3%
Manulife (Manufacturers Life Insurance)
45
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$197K +$25.7K +116 +12%
Janney Montgomery Scott
46
Janney Montgomery Scott
Pennsylvania
$185K – – –
State Board of Administration of Florida Retirement System
47
State Board of Administration of Florida Retirement System
Florida
$176K +$34.5K +156 +20%
ECM
48
ExodusPoint Capital Management
New York
$165K +$198K +893 New
CS
49
Credit Suisse
Switzerland
$163K +$1.77K +8 +0.9%
ProShare Advisors
50
ProShare Advisors
Maryland
$155K +$25.7K +116 +16%
1
2
3 4

NGNE Hedge Fund Activity: Q2 2021 in Review

82 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Neurogene (NGNE) for Q2 2021, worth a combined $249M — down 27% from $342M a quarter earlier.

Fund positioning in NGNE was balanced in Q2 2021: 9 funds opened new positions, 9 closed out, 27 added to existing stakes and 24 trimmed.

The largest buyer was Candriam SCA, adding an estimated $5.66M. The largest seller was EcoR1 Capital, cutting an estimated $8.45M.

  • 82 institutional investors held Neurogene (NGNE) as of Q2 2021, unchanged from Q1 2021.
  • Funds reported $249M of Neurogene stock for Q2 2021, down 27% quarter-over-quarter.
  • 9 funds opened new Neurogene positions in Q2 2021 and 9 closed out, a net change of 0 holders.
  • The largest Neurogene buyer in Q2 2021 was Candriam SCA, an estimated $5.66M added.
  • The largest Neurogene seller in Q2 2021 was EcoR1 Capital, an estimated $8.45M sold.

Based on aggregated 13F filings for Q2 2021.